- £246.54m
- £258.39m
- £87.60m
- 89
- 17
- 59
- 56
Annual income statement for Idox, fiscal year end - October 31st, GBP millions except per share, conversion factor applied.
R2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 57.3 | 62.2 | 66.2 | 73.3 | 87.6 |
| Cost of Revenue | |||||
| Gross Profit | 42.5 | 45.1 | 51.1 | 57.2 | 63.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 53.3 | 54.5 | 57.5 | 63.9 | 77.6 |
| Operating Profit | 3.99 | 7.64 | 8.66 | 9.34 | 10 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.81 | 7.27 | 6.6 | 7.82 | 8.06 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.477 | 6.03 | 5.61 | 5.58 | 5.26 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.28 | 11.9 | 5.04 | 5.58 | 5.26 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.28 | 11.9 | 5.04 | 5.58 | 5.26 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.004 | 0.013 | 0.014 | 0.014 | 0.014 |
| Dividends per Share |